Sanofi Exec On Go-To-Market Models, MLR Reviews, Ambidextrous Leadership

Sanofi’s EVP (general medicines), Olivier Charmeil, talks about pharma’s evolving go-to-market strategies that enmesh a more personalized, data-driven approach, why the medical, legal, and regulatory (MLR) review process needs to be faster and also impressive learnings from Amazon, Netflix and Ikea around building customer experience.

Sanofi Exec Talks About Evolving Go-To-Market Models

The shift in pharma’s go-to-market models driven by the growing relevance of a personalized, data-driven approach, the need for ambidextrous leadership and learnings from Amazon, Netflix and Ikea were some of key topics that were discussed at the opening session of Indegene’s Digital Summit 2024.

More from Scrip

More from Business